Thrill Bill Due, Heartbreak Therapy, & Fuelish Mistake
Good morning! ☀️
Six Flags is tapping out at two parks (RIP to thrill rides and cotton candy logistics in Maryland), biotech firm Capricor just got friend-zoned by the FDA, and Ford slammed the brakes on over 850,000 vehicles—including fleet favorites like the F-150 and Super Duty. If your day was cruising in neutral, it’s about to hit a few potholes. Let’s dash.
“The real test is not whether you avoid this failure because you won’t. It’s whether you let it harden or shame you into inaction, or whether you learn from it; whether you choose to persevere.”
🎢 Thrill’s Over—Six Flags Is Closing Two Parks
Big news in the theme park world: Six Flags just announced it’s pulling the plug on two of its locations. Maryland’s Six Flags America (plus Hurricane Harbor) will be shutting down after the 2025 season. Out west, California’s Great America will hang on until at least the end of 2027 before the gates close for good.
The reasons? One park’s land is being redeveloped, the other’s lease is expiring—and neither park was exactly crushing it in profit margins. Harsh? Maybe. Strategic? Definitely.
✅ Jersey’s Great Adventure is safe (for now).
🚫 But if you’re near Maryland or the Bay Area, time’s ticking.
Why it matters (Logistics Edition):
Park closures don’t just hurt thrill-seekers—they slam supply chains. We’re talking lost freight volume for ride parts, uniforms, seasonal merch, and more. Redevelopment zones mean shifting delivery patterns, zoning headaches, and fewer recurring loads.
🔥 Hot Take:
When Six Flags says exit left, the logistics world feels it. Amusement parks move more than people—they move product. And when that pipeline dries up, local freight doesn’t just stall—it hits a dead end.
🚫 FDA Pumps the Brakes on Capricor’s Duchenne Therapy
Capricor just got a big “not yet” from the FDA. The agency rejected its marketing application for deramiocel—a cell therapy targeting cardiomyopathy in Duchenne muscular dystrophy patients—saying the data didn’t show enough proof it actually works. The therapy, submitted back in December, would’ve been the first FDA-approved treatment specifically for DMD-related heart issues.
Now? Back to the clinical drawing board.
🧬 Why It Matters (Logistics Edition):
This isn’t just a biotech bummer—it’s a freight delay in disguise. Regulatory setbacks like this hit pause on everything from manufacturing to cold chain shipments and clinical supply distribution. If you’re in pharma logistics or looking to expand into life sciences transport, this is your reminder: until the FDA greenlights it, there’s nothing to ship.
🔥 Hot Take:
The FDA doesn’t care about your revenue forecast. No approval = no payload. In the life sciences lane, hope isn’t a supply chain strategy. Secure the greenlight, then start the engines.
🚨 Ford Recall Alert: Over 850K Vehicles at Risk of Engine Stall
Ford just hit the brakes on more than 850,000 vehicles—including F-150s, Broncos, Mustangs, Explorers, Super Duty trucks, and Lincoln SUVs—from model years 2021–2023. Why? A faulty low-pressure fuel pump could cause engines to stall mid-drive. According to the NHTSA, about 10% of these rides might be affected. Cue the engine misfires, power dips, and check engine lights—especially if you're running low on fuel or driving in hot weather.
No official fix yet, but Ford says it's coming. In the meantime, maybe top off that tank and cross your fingers.
Why It Matters (Logistics Edition):
If you’re moving freight and relying on Blue Ovals to do it, this recall is more than an inconvenience—it’s a delivery disruptor. Downtime = missed routes, customer complaints, and supply chain ripple effects.
🔥 Hot Take:
Your trucks might be tough—but if your fleet’s running on recall notices, your margins just took a hit. In 2025, uptime isn’t optional—it’s your competitive edge.
The Workday Dash is an aggregation of articles regarding the transportation logistics, trucking, and supply chain industries for July 31, 2025, from iLevel Logistics Inc.